Ajinomoto

Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium

Retrieved on: 
Tuesday, March 26, 2024
Well, Dicarboxylic acid, University, Culture, B cell, Ajinomoto, Growth, Cell, Drug discovery, Biomedical Research, Active ingredient, Good manufacturing practice, Research, GMP, University of Tokyo, Regenerative medicine, API, Good, Amino acid, Multimedia, IPSC, Fine chemical

TOKYO, March 26, 2024  /PRNewswire/ -- Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium. The enhanced version of its widely used StemFit™ products is designed to improve the growth and pluripotency of induced pluripotent stem cells (iPSC) and meet the Good Manufacturing Practice (GMP) standards for Active Pharmaceutical Ingredients (API).

Key Points: 
  • TOKYO, March 26, 2024 /PRNewswire/ -- Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium.
  • The product line-up of StemFit™ is ideal for regenerative medicine, drug discovery and disease modeling.
  • Additionally, it also enhances further manufacturing of cellular medicines, ensuring superior performance and reliability in iPSC culture.
  • The Group's expertise in GMP API production contributes to the superior performance of the StemFit™ medium, ensuring it meets the highest industry standards.

Ajinomoto Co. Launches Silicon Valley CVC HQ to Grow U.S. Investments, Adds New Portfolios

Retrieved on: 
Tuesday, February 13, 2024
Robotics, ICT, Dicarboxylic acid, AI, Investment, Computer, Health, Growth, Ajinomoto, Food, CDMO, Health care, Medium (website), Wellness, Green, Semiconductor, CVC, Fermentation, Research, Partnership, Fine chemical

The CVC arm has been actively deploying capital with new fund-on-fund and direct investments. Its growing portfolio now includes Translink Capital -- a U.S.-based early-stage venture capital firm investing in semiconductors, mobility, AI, healthcare, robotics, and sustainability. The CVC arm has also made its first semiconductor investment in Elephantech -- a manufacturing technology company advancing metal inkjet printed circuit boards as a more sustainable production process.

Key Points: 
  • The aim is to back innovators in the company's four growth areas, "Healthcare," "Food & Wellness," "ICT," and "Green."
  • It also refers to the Ajinomoto Group's unique scientific approach to connect these findings and services to help resolve social issues and contribute to well-being.
  • Ajinomoto Co.'s New CVC arm in Silicon Valley: https://cdn.kyodonewsprwire.jp/prwfile/release/M107658/202402066250/_prw...
    With its new team in Silicon Valley, the CVC arm will strengthen its funding and partnership support to startups while driving growth across the Ajinomoto Group's food, healthcare, and electronic material business verticals.
  • In semiconductors, Ajinomoto Co. is a pioneer of film-based circuit insulation technology that has become a benchmark component in today's computers.

ABF (Ajinomoto Build-up Film) Market Size was Valued at USD 537.5 Million in 2024 and is Anticipated to Grow USD 845.4 Million by 2030 at a CAGR of 7.8% | Valuates Reports

Retrieved on: 
Monday, January 8, 2024
Car, Server, Electronics, Internet, Ajinomoto, USD, Tablet, Growth, ABF, PC

The global ABF (Ajinomoto Build-up Film) Market was valued at USD 482.5 Million in 2023 and is anticipated to reach USD 845.4 Million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.

Key Points: 
  • The global ABF (Ajinomoto Build-up Film) Market was valued at USD 482.5 Million in 2023 and is anticipated to reach USD 845.4 Million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
  • The market for Ajinomoto Build-up Film (ABF) is closely related to the ongoing developments in semiconductor packaging technology.
  • Packaging solutions that enable improved performance and compactness are in greater demand as electronic devices get lighter, smaller, and more complicated.
  • Due to its remarkable dielectric and insulating qualities, ABF has become an essential part of modern semiconductor packaging, which propels the market's growth.

ABF (Ajinomoto Build-up Film) Market Size was Valued at USD 537.5 Million in 2024 and is Anticipated to Grow USD 845.4 Million by 2030 at a CAGR of 7.8% | Valuates Reports

Retrieved on: 
Monday, January 8, 2024
Car, Server, Electronics, Internet, Ajinomoto, USD, Tablet, Growth, ABF, PC

The global ABF (Ajinomoto Build-up Film) Market was valued at USD 482.5 Million in 2023 and is anticipated to reach USD 845.4 Million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.

Key Points: 
  • The global ABF (Ajinomoto Build-up Film) Market was valued at USD 482.5 Million in 2023 and is anticipated to reach USD 845.4 Million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
  • The market for Ajinomoto Build-up Film (ABF) is closely related to the ongoing developments in semiconductor packaging technology.
  • Packaging solutions that enable improved performance and compactness are in greater demand as electronic devices get lighter, smaller, and more complicated.
  • Due to its remarkable dielectric and insulating qualities, ABF has become an essential part of modern semiconductor packaging, which propels the market's growth.

Accenture to Acquire Rabbit’s Tale to Strengthen Its Creative & Digital Customer Experience Capabilities in Southeast Asia

Retrieved on: 
Wednesday, November 29, 2023
Technology, Marketing, Advertising, Other Technology, Communications, Professional Services, Business, Software, Networks, Data Management, Acquisition, NYSE, Creativity, Ajinomoto, Tale, Multimedia, Charoen Pokphand, Growth, Art Data Interactive, Siam Commercial Bank, Creative industries, Accenture, Electrolux

Accenture (NYSE: ACN) has agreed to acquire Rabbit’s Tale , a Bangkok-based creative and digital experience agency.

Key Points: 
  • Accenture (NYSE: ACN) has agreed to acquire Rabbit’s Tale , a Bangkok-based creative and digital experience agency.
  • The move will significantly strengthen the regional creative, brand and data capabilities of Accenture Song —the world’s largest tech-powered creative group—and help our clients build and optimize digital experiences across the entire customer lifecycle for growth in Thailand.
  • The move will take advantage of the growing importance of digital ad spending for brand differentiation and customer connection.
  • They are also looking for creative solutions and transformative programs to advance growth,” said Thomas Mouritzen, Southeast Asia lead for Accenture Song.

Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1

Retrieved on: 
Monday, November 13, 2023
Health, Genetics, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Acquisition, TYO, CDMO, Patient, Ice, ASV, CGMP, Growth, Health care, Corporate title, Ajinomoto, Pharmaceutical industry, Forge

Ajinomoto Co., Inc. ("Ajinomoto Co."; TYO: 2802) and Forge Biologics (Forge), announced today that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million1.

Key Points: 
  • Ajinomoto Co., Inc. ("Ajinomoto Co."; TYO: 2802) and Forge Biologics (Forge), announced today that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million1.
  • All development and manufacturing is done at the Hearth, Forge’s 200,000 square foot custom-designed cGMP facility in Columbus, Ohio, where the business has over 300 employees.
  • “Our teams share a commitment to investing in innovation that helps our clients succeed in delivering therapies to patients in need.
  • Upon completion, Forge will become a fully consolidated subsidiary of Ajinomoto Co., Inc. Centerview Partners LLC served as lead financial advisor and Ice Miller LLP served as legal advisor to Forge in the transaction.

Centric PLM for Food & Beverage and Grocery Has Strong Market Adoption

Retrieved on: 
Tuesday, December 5, 2023
Adobe, SNS, NRF, Name, SPC, Food, Microsoft Office, PLM, Multimedia, Trust, Foodservice, Marketing, Cosmetics, Land-O-Sun, ERPs, Ferrero, Communication, R, Retail, Centric Software, Centric, Ajinomoto, GDSN, Video game, Industrial design

CAMPBELL, Calif. , Dec. 5, 2023 /PRNewswire-PRWeb/ --  Centric Software® is pleased to announce that Centric PLM™ for Food & Beverage and Grocery is experiencing strong market adoption and value expansion. Centric Software provides the most innovative enterprise solutions to plan, design, develop, source, buy, price, sell and replenish products such as multi-category retail, grocery, food & beverage, cosmetics & personal care to achieve strategic and operational digital transformation goals.

Key Points: 
  • Centric PLM for Food Producers, Brands and Retailers Proving Key to Strategic Transformation
    CAMPBELL, Calif. , Dec. 5, 2023 /PRNewswire-PRWeb/ -- Centric Software ® is pleased to announce that Centric PLM™ for Food & Beverage and Grocery is experiencing strong market adoption and value expansion.
  • Since PLM market leader Centric Software entered this vertical about 3 years ago, hundreds of market-driven enhancements, innovations and best practices have been incorporated into Centric PLM and Centric Visual Boards™.
  • Today, over 50 food, beverage, cosmetics and personal care producers, brands and retailers—from multi-billion-dollar organizations to vegan food startups—have selected Centric solutions to strengthen their market position and streamline commercialization.
  • See Centric solutions for Food & Beverage in action at NRF 2024, Booth #6257, or https://www.centricsoftware.com/l/35842/2023-12-04/wc8qdp [request a demo].

EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis

Retrieved on: 
Wednesday, October 25, 2023
Chemicals, Plastics, Retail, Manufacturing, Technology, Pharmaceutical, Supply Chain Management, Infectious Diseases, Artificial Intelligence, Transport, Science, Biotechnology, Logistics, Health, Research, Medical Supplies, Physiology, Uridine, FDA, CGMP, Pfizer–BioNTech COVID-19 vaccine, Therapy, Vaccine, RNA, CDMO, Enzyme, R, Ajinomoto, Hoarding, COVID-19, World Health Organization, Medicine, Messenger, Nobel Prize in Physiology or Medicine, Nobel Prize, Pseudouridine, Fine chemical, Pharmaceutical industry

The companies said they had already synthesized enough pseudouridine for more than half a billion doses of vaccine in a facility that is fully cGMP* compliant.

Key Points: 
  • The companies said they had already synthesized enough pseudouridine for more than half a billion doses of vaccine in a facility that is fully cGMP* compliant.
  • The enzymatic process EnginZyme has perfected is cleaner and more efficient than the chemical synthesis methods currently used.
  • A critical impurity, alpha-pseudouridine, which is a by-product of the chemical synthesis of beta-pseudouridine, is eliminated in EnginZyme's patented enzymatic synthesis.
  • This project with EnginZyme has been particularly rewarding because of its potential to improve the global supply chain for vaccine ingredients.”
    N1-methylpseudouridine-5’-triphosphate, which is derived from pseudouridine, helps stabilize and reduce the immunogenicity of mRNA.

transcosmos helps Ajinomoto Group run AJI MALL, the Group's e-commerce website

Retrieved on: 
Monday, October 23, 2023
MA, CX, Associate, NYSE, OMS, AJI, Ajinomoto, Environment, ID, IDS, Marketing, Shopify, Running, CRM, D2C, Accounting, ERP, Online shopping, Retail, Sales, Kerosene, Transcosmos Stadium Nagasaki

TOKYO, Oct. 23, 2023 /PRNewswire-PRWeb/ -- transcosmos inc. hereby announces that the company has built AJI MALL, Ajinomoto Group's D2C (direct-to-consumer) e-commerce mall powered by Shopify, and offered e-commerce operations services to the Ajinomoto Group. Not only creating a shopping-mall design website and web content specific to each brand, transcosmos has also linked member data stored in Ajinomoto Group's common ID platform - AJINOMOTO ID - to the website, connected actual data stored in the order management system with an ERP (enterprise resource planning) system, as well as deploying a CRM tool "b->dash." Ultimately, transcosmos has built and offered an environment and a framework that enable Ajinomoto Group to disseminate worldviews of its various D2C brands from the website.

Key Points: 
  • Ultimately, transcosmos has built and offered an environment and a framework that enable Ajinomoto Group to disseminate worldviews of its various D2C brands from the website.
  • As a strategy to make more Ajinomoto brand fans on the online mall, Ajinomoto Group plans to add more new brands going forward.
  • transcosmos, a Shopify Plus Partner, has helped Ajinomoto Group launch AJI MALL, the Group's D2C (direct-to-consumer) e-commerce platform.
  • transcosmos didn't stop there and created an AJI MALL guideline/rulebook summarizing all specifications of AJI MALL to help Ajinomoto Group smoothly roll out new brands on the site.

Particle Dynamics Announces Anish Parikh as New Chief Commercial Officer

Retrieved on: 
Friday, August 25, 2023
Health, Technology, Manufacturing, Health Technology, Other Technology, Other Manufacturing, Pharmaceutical, Rutgers University, Curia, MBB, Ajinomoto, OSD, Psychology, Catalent, Microsoft Dynamics 365, Marketing, Management, Fine chemical

Particle Dynamics, a leader in oral solid dosage (OSD) technologies for the pharmaceutical sector, has appointed Anish Parikh as its Chief Commercial Officer, effective today.

Key Points: 
  • Particle Dynamics, a leader in oral solid dosage (OSD) technologies for the pharmaceutical sector, has appointed Anish Parikh as its Chief Commercial Officer, effective today.
  • Anish's appointment is a significant step for Particle Dynamics, signaling a commitment to delivering increased value to clients and stakeholders.
  • Nicolas Fortin, Chief Executive Officer of Particle Dynamics, shared, “We're pleased to have Anish lead our commercial team.
  • His background aligns well with our commitment to offering the industry top-notch technologies and excellent service.”
    Anish brings over 25 years of industry experience to Particle Dynamics.